S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
S&P 500   4,283.74 (+0.23%)
DOW   33,999.04 (+0.06%)
QQQ   329.28 (+0.24%)
AAPL   174.15 (-0.23%)
MSFT   290.17 (-0.39%)
META   174.66 (-0.11%)
GOOGL   120.17 (+0.52%)
AMZN   142.30 (+0.14%)
TSLA   908.61 (-0.37%)
NVDA   187.73 (+2.39%)
NIO   19.91 (-0.85%)
BABA   90.74 (+1.08%)
AMD   100.44 (+2.21%)
T   18.43 (+0.05%)
MU   62.98 (+2.21%)
CGC   3.81 (-6.16%)
F   16.15 (+0.75%)
GE   79.21 (-0.89%)
DIS   122.67 (-0.11%)
AMC   19.29 (-9.69%)
PYPL   99.86 (+0.44%)
PFE   48.58 (-1.40%)
NFLX   245.17 (+1.67%)
NASDAQ:HSDT

Helius Medical Technologies - HSDT Institutional Ownership

$0.50
-0.02 (-3.83%)
(As of 08/18/2022 05:26 PM ET)
Add
Compare
Today's Range
$0.46
$0.52
50-Day Range
$0.48
$1.99
52-Week Range
$0.45
$15.45
Volume
5.02 million shs
Average Volume
1.30 million shs
Market Capitalization
$1.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00

Institutional Ownership Changes (13F Filings) for Helius Medical Technologies (NASDAQ:HSDT)

Current
Institutional Ownership
Percentage
29.74%
Number of
Institutional Buyers
(last 12 months)
5
Total
Institutional Inflows
(last 12 months)
$2.64 M
Number of
Institutional Sellers
(last 12 months)
5
Total
Institutional Outflows
(last 12 months)
$385,811.21
Skip Chart & View Institutional Buying and Selling Data

HSDT Institutional Buying and Selling by Quarter

Get HSDT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Helius Medical Technologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Helius Medical Technologies Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
7/20/2022Delta Investment Management LLC26,784$32K0.0%-31.8%0.705%
5/13/2022Vanguard Group Inc.54,692$0.18M0.0%-31.3%1.439%
2/15/2022Kepos Capital LP100,304$0.52M0.0%+296.4%4.190%
2/14/2022Altium Capital Management LP48,862$0.25M0.1%N/A2.041%
2/11/2022Rovida Advisors Inc.26,934$0.14M0.0%-27.1%1.125%
2/10/2022AIGH Capital Management LLC250,000$1.30M0.4%N/A10.443%
2/3/2022ACT Capital Management LLC35,263$0.18M0.1%-50.1%1.473%
11/16/2021ACT Capital L.L.C.70,616$1.02M0.5%+19.3%2.950%
11/12/2021Renaissance Technologies LLC37,270$0.54M0.0%-9.0%1.604%
11/12/2021Delta Investment Management LLC37,184$0.54M0.2%N/A1.601%
8/17/2021Worth Venture Partners LLC17,915$0.30M0.1%-24.7%0.771%
8/13/2021Renaissance Technologies LLC40,970$0.70M0.0%-8.1%1.764%
8/13/2021Geode Capital Management LLC16,390$0.28M0.0%+57.2%0.706%
8/13/2021Vanguard Group Inc.78,898$1.34M0.0%+186.4%3.396%
8/10/2021Isthmus Partners LLC5,595$95K0.0%N/A0.241%
5/19/2021Worth Venture Partners LLC23,785$0.43M0.2%N/A1.027%
5/14/2021Rovida Advisors Inc.36,934$0.65M0.0%-97.1%1.594%
5/13/2021Renaissance Technologies LLC44,570$0.80M0.0%-96.1%1.924%
5/13/2021Kepos Capital LP25,304$0.46M0.0%N/A1.092%
5/12/2021Geode Capital Management LLC10,426$0.19M0.0%N/A0.450%
5/12/2021UBS Group AG2,305$41K0.0%+1,180.6%0.099%
5/7/2021BlackRock Inc.3,041$55K0.0%-97.1%0.131%
3/25/2021Rollins Financial100,000$38K0.0%N/A4.327%
2/16/2021Isthmus Partners LLC195,829$74K0.0%-4.4%8.474%
2/10/2021Renaissance Technologies LLC1,139,288$0.43M0.0%+9.2%76.771%
2/5/2021BlackRock Inc.106,546$41K0.0%+2.2%7.103%
7/30/2020Camelot Portfolios LLC90,000$38K0.0%N/A0.216%
5/15/2020Sabby Management LLC746,316$0.25M0.1%N/A2.881%
2/13/2020Renaissance Technologies LLC166,505$0.16M0.0%+1,132.9%0.549%
2/4/2020Virtu Financial LLC85,388$83K0.0%N/A0.282%
11/27/2019Millennium Management LLC207,895$0.34M0.0%+627.9%0.803%
8/14/2019Morgan Stanley14,072$31K0.0%+302.7%0.054%
8/14/2019Paloma Partners Management Co80,400$0.18M0.0%N/A0.310%
8/14/2019Vanguard Group Inc.684,257$1.51M0.0%-16.5%2.926%
8/14/2019A.R.T. Advisors LLC15,748$35K0.0%N/A0.067%
8/14/2019Weiss Asset Management LP25,568$56K0.0%N/A0.109%
8/13/2019BlackRock Inc.160,590$0.35M0.0%-82.5%0.687%
8/13/2019Parametric Portfolio Associates LLC23,986$53K0.0%-35.2%0.103%
8/13/2019Northern Trust Corp193,414$0.43M0.0%-6.4%0.827%
8/10/2019Isthmus Partners LLC205,829$0.45M0.1%-48.0%0.880%
8/9/2019Bank of Montreal Can20,701$45K0.0%+6,777.4%0.089%
4/1/2019Deutsche Bank AG32,448$0.30M0.0%-18.9%0.139%
2/14/2019Bank of America Corp DE14,279$0.13M0.0%+61.6%0.056%
2/14/2019Polar Capital LLP400,000$3.66M0.0%N/A1.569%
2/13/2019Geode Capital Management LLC184,087$1.69M0.0%+47.9%0.722%
2/12/2019Northern Trust Corp204,962$1.88M0.0%+26.4%0.804%
2/11/2019Scotia Capital Inc.16,855$0.15M0.0%N/A0.066%
2/11/2019Bank of New York Mellon Corp47,827$0.44M0.0%+14.5%0.188%
2/8/2019BlackRock Inc.899,400$8.24M0.0%+12.0%3.527%
2/4/2019Isthmus Partners LLC205,829$1.89M0.6%-5.9%0.807%
1/31/2019Rhumbline Advisers20,263$0.19M0.0%+54.8%0.079%
1/30/2019Trust Co. of Vermont3,000$27K0.0%N/A0.012%
1/25/2019Pembroke Management LTD795,649$9.88M1.3%-5.7%3.120%
1/1/2019TIAA CREF Investment Management LLC20,377$0.20M0.0%-18.5%0.080%
12/13/2018Vanguard Group Inc857,423$8.39M0.0%-0.6%3.362%
11/9/2018CIBC World Markets Inc.10,367$0.10M0.0%N/A0.044%
11/9/2018BlackRock Inc.803,164$7.86M0.0%+9.4%3.435%
11/7/2018JPMorgan Chase & Co.15,146$0.15M0.0%-58.1%0.065%
9/18/2018Northern Trust Corp36,145$0.34M0.0%N/A0.155%
8/9/2018BlackRock Inc.734,407$6.99M0.0%N/A3.141%
8/8/2018Schwab Charles Investment Management Inc.30,500$0.29M0.0%N/A0.130%
8/6/2018Bank of New York Mellon Corp41,755$0.40M0.0%N/A0.179%
8/6/2018Rhumbline Advisers13,825$0.13M0.0%N/A0.059%
8/2/2018Isthmus Partners LLC236,934$2.26M0.6%+67.8%1.013%
7/27/2018Pembroke Management LTD843,499$10.27M1.0%N/A3.608%
7/25/2018Pier 88 Investment Partners LLC19,430$0.19M0.1%N/A0.083%
(Data available from 1/1/2016 forward)













HSDT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of HSDT shares?

During the previous two years, 15 institutional investors and hedge funds held shares of Helius Medical Technologies. The most heavily invested institutionals were AIGH Capital Management LLC ($1.30M), ACT Capital L.L.C. ($1.02M), Renaissance Technologies LLC ($0.54M), Kepos Capital LP ($0.52M), Worth Venture Partners LLC ($0.30M), Geode Capital Management LLC ($0.28M), and Altium Capital Management LP ($0.25M).Learn more on HSDT's institutional investors.

What percentage of Helius Medical Technologies stock is owned by institutional investors?

29.74% of Helius Medical Technologies stock is owned by institutional investors. Learn more on HSDT's institutional investor holdings.

Which institutional investors have been buying Helius Medical Technologies stock?

Of the 13 institutional investors that purchased Helius Medical Technologies stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: AIGH Capital Management LLC ($0.25M), Kepos Capital LP ($0.10M), Rollins Financial ($100K), Renaissance Technologies LLC ($96.21K), Vanguard Group Inc. ($51.35K), Altium Capital Management LP ($48.86K), and Delta Investment Management LLC ($37.18K).

How much institutional buying is happening at Helius Medical Technologies?

Institutional investors have bought a total of 745,531 shares in the last 24 months. This purchase volume represents approximately $4.82M in transactions.

Which Helius Medical Technologies major shareholders have been selling company stock?

The following institutional investors have sold Helius Medical Technologies stock in the last 24 months: Rovida Advisors Inc. ($1.27M), Renaissance Technologies LLC ($1.10M), BlackRock Inc. ($0.10M), ACT Capital Management LLC ($35.35K), Vanguard Group Inc. ($24.89K), Delta Investment Management LLC ($12.50K), and Isthmus Partners LLC ($9K).

How much institutional selling is happening at Helius Medical Technologies?

Institutional investors have sold a total of 2,558,896 shares in the last 24 months. This volume of shares sold represents approximately $44.69M in transactions.

This page (NASDAQ:HSDT) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.